Search

everythinglearnresearchcommunity

for

Search:↓

Low iron and vitamin B12 levels are common in women with chronic hair loss, while low vitamin D is less common.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Women with PCOS and hair loss have lower levels of the protein gelsolin in their blood.

Chemical fingerprints can distinguish Eclipta prostrata from Wedelia calendulacea to prevent confusion and adulteration.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

Oral testosterone therapy raises heart risk more than other methods.

Testosterone increases certain kidney protein levels, potentially raising blood pressure.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Human hair shows promise for non-invasive medical testing, but more research is needed to standardize its use.

The internet has accurate information on Polycystic Ovarian Syndrome, but it's not high quality or easy to read, so we need better, user-friendly resources.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Vitamin D might help treat alopecia areata.

Certain metabolites can either protect against or increase the risk of hair loss.

Managing lipids may help treat hair loss.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

New treatments like low-level laser therapy, platelet-rich plasma therapy, and micro needling show positive results for hair regrowth in people with genetic hair loss.

Low testosterone levels may contribute to female pattern hair loss in men.

Estrogen alone can lower testosterone in some transfeminine people.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

The patient likely has Chrousos syndrome, a rare condition causing insensitivity to glucocorticoids, requiring high-dose dexamethasone treatment.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Adolescents with PCOS have higher levels of certain androgens, which are linked to hair growth but don't help diagnose PCOS better than testosterone levels.

Girls with PCOS have higher levels of certain androgens, which are linked to excess hair growth, but these androgens don't help diagnose PCOS.

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

A new compound that could treat various androgen-related conditions was created and analyzed.

ASLNC168501 can help treat hair loss by restoring hair follicle stem cell function.